Target intelligence / Profile preview

Kelch-like protein 26 (KLHL26)

Target
KLHL26
Molecular classification
Other (Kelch-like protein), Adaptor protein of cullin-RING ubiquitin ligase complex (CRL3), Contains: BTB/POZ domain, BACK domain, Kelch repeats
01

Overview

Kelch-like protein 26 (KLHL26) is a member of the Kelch-like (KLHL) family, which is characterized by the presence of a BTB/POZ domain for protein dimerization, a BACK domain of unclear function, and a series of Kelch repeats that form a β-propeller structure for substrate recognition. KLHL26 is predicted, by homology with better-studied KLHL proteins, to function as a substrate adaptor for the CUL3-based E3 ubiquitin ligase complex in the ubiquitin-proteasome system, directing protein substrates for ubiquitination and subsequent degradation. KLHL26 is highly expressed in muscle tissues, and a rare coding variant has been documented to segregate with Ebstein’s anomaly and left ventricular noncompaction in a multigenerational family, implicating it (though not conclusively proving it) in cardiac development through protein turnover pathways. No experimental drugs, biomarker uses, or broad disease roles beyond this rare cardiac defect have been described.

Other names
KLHL26Kelch-like protein 26Kelch-like family member 26kelch-like 26
02

Mechanism of action

Not applicable; no known drugs or inhibitors

03

Biological functions

Putative regulation of protein ubiquitination (as substrate adaptor for E3 ubiquitin ligase complex, likely via CUL3)Protein-protein binding (general function predicted from domain structure, exact functions not experimentally validated)Role in striated muscle cell homeostasis suggested from animal models and analogous proteins
04

Disease associations

Congenital heart disease (Ebstein’s anomaly, left ventricular noncompaction)—a rare familial variant has been implicated in a segregating pedigreePotential Mendelian disease gene (single family study)No robust evidence for roles in cancer or other major diseases to date
05

Safety considerations

None reported in the context of therapeutic intervention; clinical significance is limited to genetic findings in familial heart disease
06

Interacting drugs

None known
07

Biomarkers

None established for patient selection or monitoring

Beyond the preview

Go deeper on Kelch-like protein 26 (KLHL26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 26 (KLHL26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call